-
Raman’s cardiovascular research team. This role is embedded within a cutting-edge programme focused on integrating high-dimensional datasets, including advanced cardiac MRI (oxygen-sensitive, metabolic, and
-
renewable award. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of approaches including targeted genetic murine models, primary cell
-
computational workflows on a high-performance cluster. You will test hypotheses using data from multiple sources, refining your approach as needed. The role also involves close collaboration with colleagues
-
Metabolism (OCDEM) on studies related to circadian rhythms in population health. This post is part of a large, interdisciplinary research programme, offering attractive opportunities to work across
-
vascular biology) alongside experience in cell biology and cell signalling in isolated primary cells. You must also have experience in phenotyping of genetically modified experimental models
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme, focused on understanding and preventing disease progression in
-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
. The main objectives of Dr Kapetanovic’s research programmes are the: • Development of novel genetic and optogenetic therapies for retinal diseases. • Investigation of innovative ocular surgical techniques
-
Haematology Unit. You will use state-of-the-art genetic tools and functional genomics to generate and characterize models of CH and ageing, including the role of the bone marrow microenvironment in
-
biochemical reconstitution, electron cryomicroscopy (cryo-EM), advanced bacterial genetics, and phage biology to explore how cells and viruses control the three-dimensional structure of DNA. We investigate how